PharmaLink Announces Acquisition of PharmaReturns

LARGO, Fla., June 12, 2023 (Newswire.com) - PharmaLink, Inc., a leading pharmaceutical reverse distributor, announced today its acquisition of Cybornetic Systems, Inc. dba PharmaReturns, Inc. In addition to expanding its national account base with top-tier clients, the purchase provides PharmaLink with an innovative technology platform for returns processing that adds Artificial Intelligence (AI) and new levels of customization to the reverse distribution process for pharmaceutical manufacturers. The Internet Managed Product Returns Solution (IMPRS) currently supports returns processing operations for over 400 pharmaceutical manufacturers in the United States. 

PharmaLink CEO & President, Thierry Beckers, was noted saying, "The leadership team at PharmaReturns has a long history of trailblazing innovation in our industry. With shared values of integrity, quality, customer focus, and innovation, this transaction was a natural fit that greatly benefits our business; and more importantly our customers."  The transaction will be complete in June while systems integration runs through year-end 2023. The integration process will be carefully managed to ensure a smooth transition for both teams and prevent any disruption to ongoing client operations. Adam Bottie (Vice President, Corporate Strategy & Business Development) stated, "We are excited to expand our offering and capabilities to the pharmaceutical manufacturing community, the integration of Encore® and IMPRS is going to be a key element in our overall commitment to quality and a catalyst to ensure our competitive advantage in the space."  Read more >